Sjögren Disease and Myelin Oligodendrocyte Glycoprotein Antibody-Associated Optic Neuritis

J Neuroophthalmol. 2021 Mar 1;41(1):e48-e50. doi: 10.1097/WNO.0000000000000945.

Authors

Aman Mittal¹, Iyza F Baig, Arjun G Merchant, John J Chen, Jeanie J Choi, Alla Goldberg, Ore-Ofe O Adesina

Affiliation

¹ Ruiz Department of Ophthalmology and Visual Science (AM, IFB, AGM, AG, O-OOA), McGovern Medical School at the University of Texas Health Science Center at Houston (UTHealth), Houston, Texas; Robert Cizik Eye Clinic (AM, AG, O-OOA), Houston, Texas; Departments of Ophthalmology (JJC) and Neurology (JJC), Mayo Medical School, Rochester, Minnesota; Department of Diagnostic and Interventional Imaging (JC), McGovern Medical School at UTHealth, Houston, Texas; Department of Neurology (O-OOA), McGovern Medical School at UTHealth, Houston, Texas.

PMID: 32235221
DOI: 10.1097/WNO.0000000000000945

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Adult
Aquaporin 4 / immunology
Autoantibodies / blood*
Female
Fluorescein Angiography
Glucocorticoids / therapeutic use
Humans
Immunoglobulin G / blood
Infusions, Intravenous
Magnetic Resonance Imaging
Methylprednisolone / therapeutic use
Myelin-Oligodendrocyte Glycoprotein / immunology*
Optic Neuritis / diagnosis*
Optic Neuritis / drug therapy
Optic Neuritis / immunology
Sjogren's Syndrome / diagnosis*
Sjogren's Syndrome / drug therapy
Sjogren's Syndrome / immunology
Visual Acuity / physiology
Visual Fields / physiology

Substances

AQP4 protein, human
Aquaporin 4
Autoantibodies
Glucocorticoids
Immunoglobulin G
MOG protein, human
Myelin-Oligodendrocyte Glycoprotein
Methylprednisolone